OptimizeRx Non-GAAP EPS of $0.51 beats by $0.29, revenue of $32.2M beats by $1.29M
Source: SeekingAlpha
2026-03-05 16:04:54 ET
More on OptimizeRx
- OptimizeRx Stock: A Buy-The-Dip Opportunity For This Above-Average Growth Story
- Seeking Alpha’s Quant Rating on OptimizeRx
- Historical earnings data for OptimizeRx
- Financial information for OptimizeRx
Read the full article on Seeking Alpha
For further details see:
OptimizeRx Non-GAAP EPS of $0.51 beats by $0.29, revenue of $32.2M beats by $1.29M
OptimizeRx Corporation
NASDAQ: OPRX
OPRX Trading
2.29% G/L:
$6.915 Last:
182,880 Volume:
$6.85 Open:
OPRX Latest News
March 05, 2026 05:04:30 pm
UPDATE - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026 04:01:00 pm
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
OPRX Stock Data
$189,855,041
17,596,775
3.29%
31
N/A
Healthcare Providers & Services
Healthcare
US
Waltham
